Betaxolol (systemic) vs Phosphodiesterase 5 Inhibitors

Interacting Drugs
Betaxolol (systemic)
vs
Phosphodiesterase 5 Inhibitors
Security Level
Minor, Monitor Therapy
Mechanism
Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Betaxolol (systemic) vs Phosphodiesterase 5 Inhibitors